 |
 |

Diagnostic and Pathogenic Significance of Glutamate Receptor Autoantibodies
David Pleasure, MD
Arch Neurol. 2008;65(5):589-592.
Autoantibodies against glutamate receptors, first reported in Rasmussen encephalitis, have been observed in other focal epilepsies, central nervous system ischemic infarcts, transient ischemic attacks, sporadic olivopontocerebellar atrophy, systemic lupus erythematosus, and paraneoplastic encephalopathies. The detection of glutamate receptor autoantibodies is not useful in the evaluation of Rasmussen encephalitis but may be a biomarker for brain ischemia, and it is helpful in diagnosing certain paraneoplastic encephalopathies. Passive transfer of glutamate receptor autoantibodies from patients with systemic lupus erythematosus or paraneoplastic encephalopathy suggests that glutamate receptor autoantibodies can actively contribute to neurologic dysfunction.
Author Affiliation: Departments of Neurology and Pediatrics, University of California, Davis, School of Medicine, Sacramento.
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
RELATED ARTICLE
This Month in Archives of Neurology
Arch Neurol. 2008;65(5):572-573.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Subacute cerebellar ataxia and atrophy developed in a young woman with systemic lupus erythematosus whose cerebrospinal fluid was positive for antineuronal cell antibody
Iwasaki et al.
Lupus 2012;21:324-328.
ABSTRACT
| FULL TEXT
Exciting Times beyond the Brain: Metabotropic Glutamate Receptors in Peripheral and Non-Neural Tissues
Julio-Pieper et al.
Pharmacol. Rev. 2011;63:35-58.
ABSTRACT
| FULL TEXT
|